A R&D company focusing on iPSC-CAR-NK cell therapy product
Total raised: $50M
Investors 1
| Date | Name | Website |
| 09.02.2024 | Pan Lin In... | panlincap.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.09.2022 | Series A | $50M | - |
Mentions in press and media 3
| Date | Title | Description | Source |
| 04.09.2022 | Neukio Biotherapeutics Closes $50M Series A-1 Financing | Neukio Biotherapeutics, a Chinese company committed to developing cell therapy products, raised $50M... | finsmes.co... |
| 03.09.2022 | Chinese startup Neukio Biotherapeutics closes its Series A-1... | Shanghai, China-based company that develops novel cell therapy, Neukio Biotherapeutics, closed its S... | vcbay.news... |
| 02.09.2022 | Neukio Biotherapeutics completed Series A-1 financing, to ac... | SHANGHAI, Sept. 2, 2022 /PRNewswire/ -- Neukio Biotherapeutics, a company committed to developing no... | en.prnasia... |